Bolus or infusion teicoplanin for intravascular catheter associated infections in immunocompromised patients?

Journal of Antimicrobial Chemotherapy

Volumn 38, Issue 6, 1996, Pages 1091-1095

  Ley, B E ^a   Jalil, N ^b   McIntosh, J ^c   Smart, A ^c   Wilson, M ^b   Foot, A B M ^a   Millar, M R ^c  

^a BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

POLYPEPTIDE ANTIBIOTIC AGENT; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BOLUS INJECTION; CATHETER INFECTION; DRUG EFFICACY; HUMAN; IMMUNE DEFICIENCY; INTRAVASCULAR CATHETER; RETROSPECTIVE STUDY;

ADULT; ANTI-BACTERIAL AGENTS; BONE MARROW TRANSPLANTATION; CATHETERIZATION, CENTRAL VENOUS; CHILD; HUMANS; IMMUNOCOMPROMISED HOST; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; TEICOPLANIN;

EID: 0030476897     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/38.6.1091     Document Type: Article

References (11)

1. Campoli-Richards, D. M., Brogden, R. N. & Faulds, D. (1990). Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs 40, 449-86.
2. Charbonneau, P. & Garraud, J. J. (1989). Overview of infections due to coagulase-negative staphylococci and evaluation of teicoplanin in their management. In Focus on Coagulase-Negative Staphylococci (Phillips, I., Ed., pp. 95-105). Royal Society of Medicine International Congress and Symposium Series, No 151. Royal Society of Medicine Services, London.
3. Chomarat, M., Espinouse, D. & Flandrois, J.-P. (1991). Coagulase-negative staphylococci emerging during teicoplanin therapy and problems in the determination of the sensitivity. Journal of Antimicrobial Chemotherapy 27, 475-80.
4. Chow, A. W., Jewesson, P. J., Kureishi, A. & Phillips, G. L. (1993). Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients. European Journal of Haematology 54, Suppl., 18-24.
5. Greenwood, D. (1988). Microbiological properties of teicoplanin. Journal of Antimicrobial Chemotherapy 21, Suppl. A, 1-13.
6. Holt, A. & Brown, D. (1989). Antimicrobial susceptibility testing. In Medical Bacteriology: a Practical Approach (Hawkey, P. M. & Lewis, D. A., Eds), pp. 167-94. IRL Press, Oxford.
7. Kropec, A., Huebner, J., Wursthorn, M. & Daschner, F. D. (1993). In vitro activity of vancomycin and teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis colonizing catheters. European Journal of Clinical Microbiology and Infectious Diseases 12, 545-8.
8. Maki, D. G., Weise, C. E. & Sarafin, H. W. (1977). A semiquantitative culture method for identifying intravenous-catheter-related infection. New England Journal of Medicine 296, 1305-9.
9. Miles, A. A. & Misra, S. S. (1938). The estimation of the bactericidal power of the blood. Journal of Hygiene 38, 732-48.
10. O'Hare, M. D. & Reynolds, P. E. (1992). Novel membrane proteins present in teicoplanin-resistant, vancomycin-resistant, coagulase-negative Staphylococcus spp. Journal of Antimicrobial Chemotherapy 30, 753-68.
11. Weightman, N. C., Speller, D. C. E. & Darbyshire, P. J. (1985). Infection and intravenous catheters. Journal of Antimicrobial Chemotherapy 16, 275.